NEW CRYSTALLINE FORMS OF 2 -HYDROXY- 3- [5- (MORPHOLIN- 4- YLMETHYL) PYRIDIN-2-YL] IH- INDOLE- 5 -CARBONITRILE CITRATE

摘要

The present invention relates to new crystalline forms of 2-hydroxy-3-[5-(morpholin-4- ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a Form D and a Form E, respectively, a process for their preparations, pharmaceutical formulations containing said compounds and to the use of said active compounds in therapy, and particularly to GSK3 related conditions and disorders.